101 – 110 of 383
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M).
(
- Contribution to journal › Article
-
Mark
Incretin dysfunction in type 2 diabetes: Clinical impact and future perspectives.
(
- Contribution to journal › Scientific review
-
Mark
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Shifting the paradigm of islet inflammation-good guy or bad guy?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Methods and Models for Metabolic Assessment in Mice
2013) In Journal of Diabetes Research(
- Contribution to journal › Article
-
Mark
Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model.
(
- Contribution to journal › Article
-
Mark
Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function
(
- Contribution to journal › Article
-
Mark
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
(
- Contribution to journal › Article
- 2012
-
Mark
Varning för okritisk användning av överviktskirurgi vid typ 2-diabetes.
(
- Contribution to journal › Article